BCL2 and hepatocellular carcinoma: On the other hand, survivin knock-down through siRNA significantly enhanced low dose of ABT-263 to induce apoptosis in HCC cells, which further confirmed that survivin inactivation indeed plays critical roles to determine cell sensitivity to Bcl-2 inhibitor toxicity.